Literature DB >> 30275537

NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections.

Elias Abou-Samra1, Zachary Hickey1, Oscar A Aguilar2,3, Michal Scur4, Ahmad Bakur Mahmoud1,5, Sergey Pyatibrat6, Megan M Tu1, Jeffrey Francispillai1, Arthur Mortha2, James R Carlyle2,3, Mir Munir A Rahim7, Andrew P Makrigiannis8.   

Abstract

Helper-type innate lymphoid cells (ILC) play an important role in intestinal homeostasis. Members of the NKR-P1 gene family are expressed in various innate immune cells, including natural killer (NK) cells, and their cognate Clr ligand family members are expressed in various specialized tissues, including the intestinal epithelium, where they may play an important role in mucosal-associated innate immune responses. In this study, we show that the inhibitory NKR-P1B receptor, but not the Ly49 receptor, is expressed in gut-resident NK cells, ILC, and a subset of γδT cells in a tissue-specific manner. ILC3 cells constitute the predominant cell subset expressing NKR-P1B in the gut lamina propria. The known NKR-P1B ligand Clr-b is broadly expressed in gut-associated cells of hematopoietic origin. The genetic deletion of NKR-P1B results in a higher frequency and number of ILC3 and γδT cells in the gut lamina propria. However, the function of gut-resident ILC3, NK, and γδT cells in NKR-P1B-deficient mice is impaired during gastrointestinal tract infection by Citrobacter rodentium or Salmonella typhimurium, resulting in increased systemic bacterial dissemination in NKR-P1B-deficient mice. Our findings highlight the role of the NKR-P1B:Clr-b recognition system in the modulation of intestinal innate immune cell functions.

Entities:  

Keywords:  Gut-associated immune cells; Innate immunity; Innate lymphoid cells; NKR-P1B receptor; Natural killer cells

Mesh:

Substances:

Year:  2018        PMID: 30275537      PMCID: PMC6828740          DOI: 10.1038/s41423-018-0169-x

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  53 in total

1.  Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities.

Authors:  Tsuyoshi Takahashi; Sussan Dejbakhsh-Jones; Samuel Strober
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

Review 2.  Evolution of the Ly49 and Nkrp1 recognition systems.

Authors:  James R Carlyle; Aruz Mesci; Jason H Fine; Peter Chen; Simon Bélanger; Lee-Hwa Tai; Andrew P Makrigiannis
Journal:  Semin Immunol       Date:  2008-07-02       Impact factor: 11.130

Review 3.  Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut.

Authors:  David Artis
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

4.  Dedicated immunosensing of the mouse intestinal epithelium facilitated by a pair of genetically coupled lectin-like receptors.

Authors:  S Leibelt; M E Friede; C Rohe; D Gütle; E Rutkowski; A Weigert; L Kveberg; J T Vaage; M W Hornef; A Steinle
Journal:  Mucosal Immunol       Date:  2014-07-02       Impact factor: 7.313

5.  Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor.

Authors:  David B Rosen; Jayaram Bettadapura; Mohammed Alsharifi; Porunelloor A Mathew; Hilary S Warren; Lewis L Lanier
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

6.  Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells.

Authors:  Natasha K Crellin; Sara Trifari; Charles D Kaplan; Tom Cupedo; Hergen Spits
Journal:  J Exp Med       Date:  2010-02-08       Impact factor: 14.307

7.  Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors.

Authors:  James R Carlyle; Amanda M Jamieson; Stephan Gasser; Christopher S Clingan; Hisashi Arase; David H Raulet
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-27       Impact factor: 11.205

8.  Latent cytomegalovirus infection exacerbates experimental colitis.

Authors:  Chukwuma Onyeagocha; Mohammad S Hossain; Amrita Kumar; Rheinallt M Jones; John Roback; Andrew T Gewirtz
Journal:  Am J Pathol       Date:  2009-10-08       Impact factor: 4.307

9.  Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.

Authors:  Sofia Buonocore; Philip P Ahern; Holm H Uhlig; Ivaylo I Ivanov; Dan R Littman; Kevin J Maloy; Fiona Powrie
Journal:  Nature       Date:  2010-04-29       Impact factor: 49.962

10.  Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches.

Authors:  Sae-Hae Kim; Byeol-Hee Cho; Hiroshi Kiyono; Yong-Suk Jang
Journal:  Sci Rep       Date:  2017-06-21       Impact factor: 4.379

View more
  3 in total

Review 1.  Natural Killer Cells: Tumor Surveillance and Signaling.

Authors:  Lizeth G Meza Guzman; Narelle Keating; Sandra E Nicholson
Journal:  Cancers (Basel)       Date:  2020-04-11       Impact factor: 6.639

Review 2.  Type 3 Innate Lymphoid Cells as Regulators of the Host-Pathogen Interaction.

Authors:  Ana Valle-Noguera; Anne Ochoa-Ramos; Maria José Gomez-Sánchez; Aranzazu Cruz-Adalia
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

3.  Clr-f expression regulates kidney immune and metabolic homeostasis.

Authors:  Haggag S Zein; Elias Abou-Samra; Michal Scur; Alex Gutsol; Clayton W Hall; Bishal Dasgupta; Lara Gharibeh; Turki Abujamel; Daniel Medina-Luna; Gayani S Gamage; Tessa J Pelino; Mona Nemer; Mir Munir A Rahim; Alexander Steinle; Brendon D Parsons; Andrew P Makrigiannis
Journal:  Sci Rep       Date:  2022-03-22       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.